| Literature DB >> 22685485 |
Siddig Ibrahim Abdelwahab1, Loiy Elsir Ahmed Hassan, Amin M S Abdul Majid, Sakina M Ahmed Yagi, Syam Mohan, Manal Mohamed Elhassan Taha, Syahida Ahmad, Cheah Shiau Chuen, Putri Narrima, Mohd Mustafa Rais, Suvitha Syam, Bushra Abdulkarim Moharam, A Hamid A Hadi.
Abstract
Emerging evidence suggests that reactive oxygen (ROS) and nitrogen (RNS) species can contribute to diverse signalling pathways of inflammatory and tumour cells. Cucurbitacins are a group of highly oxygenated triterpenes. Many plants used in folk medicine to treat cancer have been found to contain cucurbitacins displaying potentially important anti-inflammatory actions. The current study was designed to investigate the anti-ROS and -RNS effects of cucurbitacin L 2-O-β-glucoside (CLG) and the role of these signaling factors in the apoptogenic effects of CLG on human colon cancer cells (HT-29). This natural cucurbitacin was isolated purely from Citrullus lanatus var. citroides (Cucurbitaceae). The results revealed that CLG was cytotoxic to HT-29. CLG increased significantly (P < 0.05) RNA and protein levels of caspase-3 in HT-29 cells when verified using a colorimetric assay and realtime qPCR, respectively. The results showed that lipopolysaccharide/interferon-gamma (LPS/INF-γ) increased nitrous oxide (NO) production inR AW264.7macrophages, whereas N(G)-nitro-L-argininemethyl ester (L-NAME) and CLG curtailed it. This compound did not reveal any cytotoxicity on RAW264.7 macrophages and human normal liver cells (WRL-68) when tested using the MTT assay. Findings of ferric reducing antioxidant power (FRAP) and oxygen radical absorption capacity (ORAC) assays demonstrate the antioxidant properties of CLG. The apoptogenic property of CLG on HT-29 cells is thus related to inhibition of reactive nitrogen and oxygen reactive species and the triggering of caspase-3-regulated apoptosis.Entities:
Year: 2012 PMID: 22685485 PMCID: PMC3350939 DOI: 10.1155/2012/490136
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Effect of CLG and paclitaxel on different cells type expressed as EC50 values in MTT assay.
| Cell line | Tissue of human origin | Compound EC50 ± SD ( | |
|---|---|---|---|
| Cucurbitacin L 2-O- | Paclitaxel | ||
| A549 | Non-small-cell lung cancer | >200 | 5.81 ± 1.03 |
| PC-3 | Human prostate carcinoma | >200 | 0.08 ± 0.03 |
| HepG2 | Hepatocellular carcinoma | >200 | 1.18 ± 0.24 |
| HT-29 | Colon adenocarcinoma | 79.76 ± 2.34 | 0.06 ± 0.02 |
| WRL-68 | Normal hepatic cells | >200 | 0.10 ± 0.05 |
Figure 1Fluorescent photomicrographs of cells stained Hoechst 33342 being treated with with CLG (IC50) for 24 and 48 h. (a) Control, (b) chromatin condensation in the nucleus (48 h), and (c) quantitative analysis of apoptosis (total nuclear intensity). Statistical significance is expressed as *, P < 0.05.
Figure 2The colorimetric assay of caspase-3 in colon adenocarcinoma cells (HT-29) treated and untreated with CLG (IC50) for 24 and 48 h. ANOVA showed a significant difference (*P < 0.05) between treated and untreated cells in the activity of caspase-3.
Figure 3Caspase-3 mRNA expression in HT-29. Cells were treated with CLG and then incubated with for 24 h. After incubation, cells were harvested and used real-time RTPCR analysis. Normalization relative to GAPDH was performed. Results presented in bar graph are the means ± SD of three independent experiments. The statistical significance is expressed as *, P < 0.05.
Figure 4The effects of CLG on NO production in RAW264.7 cells: cells were pretreated with the indicated concentrations of CLG, or the NO inhibitor L-NAME. The cells were stimulated with LPS and INF or were left untreated. The nitric oxide was measured using Griess assay. Data is representative of three independent experiments and was analysed using one-way ANOVA. The inhibitory effect of CLG was significantly different from stimulated cells.
Figure 5The effects of CLG on RAW264.7 cells' viability: cells were pretreated with the indicated concentrations of CLG or were left untreated. Data is the average of three independent experiments (±SD) and was analyzed using one-way ANOVA. The statistical significance is expressed as *, P < 0.05.
Figure 6Ferric reducing/antioxidant power assay. Results are expressed in μM Fe(II)/g dry mass and compared with that of ascorbic acid and quercetin. ANOVA. The statistical significance is expressed as *, P < 0.05.